Action 300630 HAINAN POLY PHARM. CO., LTD
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Hainan Poly Pharm. Co., Ltd

Actions

300630

CNE100002N10

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 30/04/2024 		Varia. 5j. Varia. 1 janv.
12,35 CNY -18,75% Graphique intraday de Hainan Poly Pharm. Co., Ltd -.--% -45,40%
08/04 Hainan Poly Pharm obtient l'autorisation de commercialiser le voriconazole injectable en Suède MT
04/04 Hainan Poly Pharm obtient le feu vert pour commercialiser un médicament contre les infections cutanées en Allemagne MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Hainan Poly Pharm Gets GMP Certificate From Saudi Authorities
Hainan Poly Pharm Gets Nod to Market Voriconazole Injection in Sweden
Hainan Poly Pharm Gets Nod to Market Skin Infection Drug in Germany
Hainan Poly Pharm's Brivaracetam Injection Gets FDA's Nod to Enter US Market; Shares Up 3%
Hainan Poly Pharm's Epilepsy Drug Gets FDA's Greenlight to Enter US Market
Hainan Poly Pharm to Apply For Up to 3.8 Billion Yuan Credit Line
Hainan Poly Pharm Gets Nod to Market Pantoprazole Sodium for Injection in Singapore
Hainan Poly Pharm. Co., Ltd(SZSE:300630) dropped from Shenzhen Stock Exchange Component A Share Index
Hainan Poly Pharm. Co., Ltd(SZSE:300630) dropped from Shenzhen Stock Exchange Component Index
Hainan Poly Pharm. Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Hainan Poly Pharm's Gets US FDA Nod to Market Iopamidol Injection
Hainan Poly Pharm Gets Approval to Market Fluconazole Dry Suspension in US
Tranche Update on Hainan Poly Pharm. Co., Ltd's Equity Buyback Plan announced on April 25, 2023.
Hainan Poly Pharm. Co., Ltd's Equity Buyback announced on April 25, 2023 has closed with 1,426,700 shares, representing 0.33% for CNY 30.03 million.
Hainan Poly Pharm's Unit Passes US FDA's On-Site Inspection
Hainan Poly Pharm. Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Hainan Poly Pharm's Unit Passes Regulator's GMP Inspection
Hainan Poly Pharm Wins FDA Nod to Market Azithromycin Variant in US
Hainan Poly Pharm. Co., Ltd Announces Dividend Implementation of Cash Dividend for 2022, Payable on 18 July 2023
Tranche Update on Hainan Poly Pharm. Co., Ltd's Equity Buyback Plan announced on April 25, 2023.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 300630
  4. Actualités Hainan Poly Pharm. Co., Ltd
  5. Autres langues